Parnax Lab Current Share Price | Parnax Lab Stock Screener
PARNAXLAB
Pharmaceuticals
Parnax Lab Current Stock Price Today
Live Share Price NSE
₹128.20
▲
4.41 (3.56%)
Live Share Price BSE
₹125.30
▲
1.50 (1.21%)
As of September 18, 2026, the live Parnax Lab share price (NSE: PARNAXLAB) is ₹128.20 on NSE and ₹125.30 on BSE, up 3.56% from the previous close, with shares trading between ₹124.00 and ₹130.00 in today's trading session, and a 52-week range of ₹119.65–₹140.78.
Browse PARNAXLAB balance sheet details to support your investment research.
Use the Parnax Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Parnax Lab Market Cap
₹138.13 Cr.
PARNAXLAB P/E Ratio (TTM)
15.92
Parnax Lab P/B Ratio
1.50
EPS (TTM)
₹10.27
Dividend Yield
-
Debt to Equity
0.97
PARNAXLAB 52 Week High
₹140.78
Parnax Lab 52 Week Low
₹119.65
Operating Margin
8.00%
Profit Margin
-
PARNAXLAB Revenue (TTM)
₹57.00
EBITDA
₹4.00
Net Income
-
Total Assets
₹228.00
Total Equity
₹95.00
Parnax Lab Current Share Price Chart
Track the current Parnax Lab share price and stock price with an interactive chart. Analyse PARNAXLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Parnax Lab stock quote in one place.
Parnax Lab Company Profile - Fundamental Screener
Screen Parnax Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PARNAXLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE383L01019
Parnax Lab Balance Sheet Screener
Screen PARNAXLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 228 | 190 | 190 | 145 | 154 | 106 | 107 | 95 | 87 | 86 |
| Current Assets | 91 | 65 | 73 | 57 | 71 | 39 | 46 | 37 | 37 | 31 |
| Fixed Assets | 126 | 88 | 90 | 77 | 72 | 60 | 58 | 51 | 44 | 47 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 37 | 32 | 35 | 20 | 24 | 19 | 22 | 23 | 18 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 95 | 83 | 72 | 62 | 48 | 33 | 33 | 36 | 33 | 31 |
| Share Capital | 12 | 12 | 12 | 12 | 10 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 84 | 72 | 60 | 51 | 37 | 24 | 24 | 27 | 24 | 23 |
Parnax Lab Income Statement Screener - Profit & Revenue Analysis
Screen Parnax Lab income statement and profit fundamentals.
Analyze PARNAXLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Parnax Lab share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57 | 72 | 64 | 63 | 54 | 50 | 40 | 49 | 50 | 47 | 51 | 43 | 49 | 41 | 47 |
| Expenses | 53 | 65 | 57 | 55 | 46 | 42 | 36 | 41 | 42 | 41 | 45 | 37 | 42 | 36 | 40 |
| EBITDA | 4 | 7 | 7 | 9 | 8 | 7 | 5 | 8 | 9 | 6 | 6 | 6 | 7 | 5 | 7 |
| Operating Profit % | 8.00% | 7.00% | 9.00% | 13.00% | 14.00% | 14.00% | 11.00% | 15.00% | 17.00% | 13.00% | 12.00% | 12.00% | 13.00% | 12.00% | 16.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | 3 | 3 | 5 | 5 | 4 | 2 | 5 | 5 | 3 | 3 | 2 | 4 | 2 | 4 |
| Tax | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 0 | 2 | 3 | 4 | 3 | 3 | 1 | 3 | 4 | 2 | 2 | 2 | 3 | 1 | 3 |
| EPS | 0.37 | 1.90 | 2.37 | 3.15 | 2.85 | 2.55 | 1.06 | 2.97 | 3.47 | 1.95 | 1.90 | 1.63 | 2.90 | 1.30 | 2.96 |
Parnax Lab Cash Flow Screener - Liquidity Fundamentals
Screen PARNAXLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 16 | 21 | 9 | 6 | 9 | 9 | 13 | 16 | 4 |
| Investing Activities | -16 | -32 | -10 | -17 | -7 | -13 | -11 | -5 | -10 | -6 |
| Financing Activities | -16 | 15 | -14 | 12 | 0 | 5 | 1 | -7 | -5 | 1 |
| Net Cash Flow | 0 | -1 | -3 | 4 | 0 | 0 | -1 | 1 | 0 | -2 |
Parnax Lab Shareholding Pattern Screener
See Parnax Lab shareholding pattern with promoter, FII, and DII holdings.
Check Parnax Lab promoter holding and ownership changes for PARNAXLAB on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.71% | 23.27% | 24.37% | 24.93% | 24.97% | 24.73% | 24.68% | 24.26% |
| Other Holding | 5.00% | 4.44% | 3.33% | 2.77% | 2.74% | 2.97% | 3.02% | 3.44% |
| Shareholder Count | 3,572 | 3,721 | 3,900 | 4,111 | 4,317 | 4,440 | 4,521 | 4,173 |
Parnax Lab Share Dividend Screener - Share Yield Analysis
Check Parnax Lab dividend history with payout and yield data.
View Parnax Lab dividend details including ex-dates and amounts for PARNAXLAB stock.
Parnax Lab Stock Index Membership
See which indices include Parnax Lab stock.
Check PARNAXLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Parnax Lab Market Events Screener - Corporate Actions
Get Parnax Lab corporate actions including splits, bonuses, and buybacks.
Check Parnax Lab stock events that may affect PARNAXLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -2.29% |
| 2026-08-26 | 2026-08-26 | Quarterly Result Announcement | NA | 0.00% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | -0.37% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -0.88% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 1.50% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.58% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 2.57% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.47% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -4.44% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.33% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 1.00% |
Parnax Lab Competitors Screener - Peer Comparison
Screen PARNAXLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 444,717 | 36.34 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 243,116 | 83.41 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 183,052 | 85.57 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 111,440 | 23.87 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 102,870 | 95.29 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 95,152 | 30.15 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 94,535 | 25.82 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 93,504 | 16.93 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 92,759 | 45.72 | 14,636 | 14.85% | 1,938 | 34.16 |
Parnax Lab Company Announcements - News Screener
Screen PARNAXLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-11 | Notice Of 44Th AGM Of The Company | - |
| 2026-09-11 | Reg. 34 (1) Annual Report. | - |
| 2026-08-26 | Notice Of Book Closure | - |
| 2026-08-26 | Board Meeting Outcome for Outcome Of BM Held Today I.E. 26Th August 2026 | - |
| 2026-08-14 | Financials Results For The Quarter And Three Months Ended June 2026. | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-08-14 | Board Meeting Outcome for Board Meeting Outcome | - |
| 2026-08-14 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-05 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Year Ended 30Th June 2026. | - |
| 2026-08-03 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-03 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |